Rivera-Piza Adriana, Choi Lynkyung, Seo Jaeeun, Lee Hyeon Gyu, Park Jiyoung, Han Sang-Ik, Lee Sung-Joon
Department of Biotechnology, Graduate School of Life Sciences & Biotechnology, College of Life Sciences & Biotechnology, Korea University, Seoul, Republic of Korea.
Department of Food and Nutrition, Hanyang University, Seoul, Republic of Korea.
J Food Biochem. 2020 Jun;44(6):e13231. doi: 10.1111/jfbc.13231. Epub 2020 Apr 13.
We investigated the effects of high amylose rice variety, Dodamssal (DO) (Oryza sativa L.), on glucose homeostasis and lipid metabolism in mice. Experiment 1: Oral administration of DO for 1 week significantly improved glucose and insulin tolerance (p < .001) and reduced plasma triglyceride and low-density lipoprotein cholesterol concentrations. Experiment 2: Administration of DO-containing diet for 5 weeks also significantly reduced fasting glucose concentrations and hepatic lipid accumulation. DO induced GLP-1, adiponectin, and PYY levels. In the liver, DO suppressed the gene expression of G6pc, key gene in gluconeogenesis and induced AKT phosphorylation. DO increased fecal bile acid excretion regulating the expression in key genes in bile acid metabolism. DO suppressed plasma Trimethylamine N-oxide and intestinal lipopolysaccharide concentrations. DO may be achieved the hypolipidemic effects by direct activation of hepatic Pparα expression and its responsive genes regulating hepatic fatty acid uptake and β-oxidation, while downregulating the hepatic fatty acid synthesis Our results demonstrate that high-fiber rice, DO, might be a potential supplement for the amelioration of insulin resistance and hyperlipidemia. PRACTICAL APPLICATIONS: The results from the present study suggest that newly developed DO (Oryza sativa L.) high amylose rice strain may improve insulin sensitivity and activates the Akt pathway. DO consumption tends to counteract the deleterious effects characterized during the intake of high-fat-diet related to plasma TG, ALT, and AST concentrations. Therefore, DO supplementation might be a potential adjuvant to ameliorate dyslipidemia and adiposity.
我们研究了高直链淀粉水稻品种“稻花香”(DO)(Oryza sativa L.)对小鼠葡萄糖稳态和脂质代谢的影响。实验1:口服DO 1周可显著改善葡萄糖和胰岛素耐受性(p <.001),并降低血浆甘油三酯和低密度脂蛋白胆固醇浓度。实验2:给予含DO饮食5周也显著降低空腹血糖浓度和肝脏脂质积累。DO可诱导胰高血糖素样肽-1(GLP-1)、脂联素和肽YY(PYY)水平升高。在肝脏中,DO抑制糖异生关键基因葡萄糖-6-磷酸酶(G6pc)的基因表达,并诱导蛋白激酶B(AKT)磷酸化。DO增加粪便胆汁酸排泄,调节胆汁酸代谢关键基因的表达。DO抑制血浆氧化三甲胺和肠道内脂多糖浓度。DO可能通过直接激活肝脏过氧化物酶体增殖物激活受体α(Pparα)表达及其响应基因来调节肝脏脂肪酸摄取和β-氧化,从而实现降血脂作用,同时下调肝脏脂肪酸合成。我们的结果表明,高纤维水稻DO可能是改善胰岛素抵抗和高脂血症的潜在补充剂。实际应用:本研究结果表明,新开发的DO(Oryza sativa L.)高直链淀粉水稻品种可能改善胰岛素敏感性并激活Akt信号通路。食用DO往往可以抵消高脂饮食摄入期间与血浆甘油三酯、谷丙转氨酶和谷草转氨酶浓度相关的有害影响。因此,补充DO可能是改善血脂异常和肥胖的潜在辅助手段。